Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-046947

Chief Scientific Officer acquired 19,302 shares (grant or award)

  • Chief Scientific Officer acquired 45,481 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kastelein Johannes Jacob Pieter · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2025-03-26 Grant or award : show line 1 in the form +19,302 169,302 I
2025-03-26 Exercise or conversion : show line 2 in the form +45,481 79,481 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-03-26 Grant or award : show line 3 in the form Restricted Stock Unit +45,481 45,481 D
2025-03-26 Exercise or conversion : show line 4 in the form Restricted Stock Unit −45,481 0 D
Loading xslF345X05/ownership.xml…